CONMED Corporation (NYSE:CNMD – Get Free Report) has received a consensus recommendation of “Reduce” from the eight research firms that are presently covering the firm, Marketbeat.com reports. Two investment analysts have rated the stock with a sell rating and six have given a hold rating to the company. The average twelve-month price target among brokers […]